Impact Biomedical (IBO) Deferred Taxes (2022)
Impact Biomedical's Deferred Taxes was -$2.58 million in FY2025, compared with $33,000 in FY2024.
Powered by 
Analysis
Impact Biomedical (IBO) Deferred Taxes (2022) Analysis & Trends
From FY2022 onward, Impact Biomedical has reported Deferred Taxes for 4 years.
- Per Business Quant data, Deferred Taxes in earlier years was $33,000 in FY2024, -$1.01 million in FY2023 and -$621,000 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -398.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Impact Biomedical | 598.41 Mn | 601.61 Mn | 2,000.00 | - |
API Access
Impact Biomedical Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();